Xiaofan Wu Selected Research

Xiaofan Wu Research Topics

Disease

10	Acute Coronary Syndrome 01/2024 - 11/2009
9	Myocardial Infarction 01/2024 - 09/2010
7	Thrombosis (Thrombus) 01/2022 - 01/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2010
3	Inflammation (Inflammations) 01/2024 - 12/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 01/2018
2	Hemorrhage 02/2022 - 01/2022
2	ST Elevation Myocardial Infarction 01/2013 - 09/2010
1	Ischemia 01/2024
1	Malnutrition (Nutritional Deficiencies) 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Ischemic Stroke 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Pancreatitis 01/2022
1	Tibial Fractures (Fracture, Tibial) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 09/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Reperfusion Injury 01/2019
1	Non-ST Elevated Myocardial Infarction 01/2019
1	Death (Near-Death Experience) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2017
1	Anemia 10/2016
1	Edema (Dropsy) 10/2016
1	Sleepiness 12/2015
1	Rhinosinusitis 12/2014
1	Hyperplasia 04/2012
1	Infarction (Infarctions) 05/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Dyslipidemias (Dyslipidemia) 01/2011
1	Calcinosis 01/2010

Drug/Important Bio-Agent (IBA)

3	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2024 - 12/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2022
2	Sirolimus (Rapamycin)FDA Link 12/2023 - 01/2010
2	TicagrelorIBA 02/2022 - 01/2022
1	AlbuminsIBA 01/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2024
1	Thyroid HormonesIBA 01/2024
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2024
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2024
1	PolymersIBA 12/2023
1	oxidized low density lipoproteinIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	Therapeutic UsesIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	pertuzumabIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 09/2019
1	Indicators and Reagents (Reagents)IBA 09/2019
1	CarbohydratesIBA 09/2019
1	AntigensIBA 09/2019
1	Carrier Proteins (Binding Protein)IBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Threonine (L-Threonine)FDA Link 11/2017
1	MAP Kinase Kinase Kinase 5IBA 11/2017
1	Bosentan (Tracleer)FDA Link 10/2016
1	macitentanIBA 10/2016
1	ambrisentan FDA Link 10/2016
1	Bortezomib (Velcade)FDA Link 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016
1	Advanced Oxidation Protein Products (AOPP)IBA 12/2015
1	Malondialdehyde (Propanedial)IBA 12/2015
1	Enterotoxins (Enterotoxin)IBA 12/2014
1	C-Reactive ProteinIBA 01/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2010
1	MetalsIBA 09/2010
1	CholesterolIBA 01/2010
1	MB Form Creatine KinaseIBA 01/2010
1	Cystatin CIBA 11/2009

Therapy/Procedure

9	Percutaneous Coronary Intervention 01/2024 - 01/2010
9	Stents 12/2023 - 01/2010
2	Drug-Eluting Stents 12/2023 - 01/2018
2	Length of Stay 01/2022 - 01/2019
2	Therapeutics 01/2022 - 01/2022
1	Glycemic Control 01/2024
1	Drug Therapy (Chemotherapy) 01/2022
1	Plasma Exchange 01/2022
1	Operative Surgical Procedures 01/2022
1	Ischemic Postconditioning 01/2019